We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Issues New Guidance for Variant-Modified COVID-19 Vaccines
EMA Issues New Guidance for Variant-Modified COVID-19 Vaccines
The European Medicines Agency (EMA) has issued new guidance outlining requirements for drug manufacturers that modify their COVID-19 vaccines to protect against several emerging variants to SARS-CoV-2.